Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps

BACKGROUND: The efficacy of dupilumab as biological treatment of severe asthma and chronic rhinosinusitis with nasal polyps (CRSwNP) depends on its ability to inhibit the pathophysiologic mechanisms involved in type 2 inflammation. OBJECTIVE: To assess in a large sample of subjects with severe asthm...

Descripción completa

Detalles Bibliográficos
Autores principales: Pelaia, Corrado, Benfante, Alida, Busceti, Maria Teresa, Caiaffa, Maria Filomena, Campisi, Raffaele, Carpagnano, Giovanna Elisiana, Crimi, Nunzio, D’Amato, Maria, Foschino Barbaro, Maria Pia, Maglio, Angelantonio, Minenna, Elena, Nolasco, Santi, Paglino, Giuseppe, Papia, Francesco, Pelaia, Girolamo, Portacci, Andrea, Ricciardi, Luisa, Scichilone, Nicola, Scioscia, Giulia, Triggiani, Massimo, Valenti, Giuseppe, Vatrella, Alessandro, Crimi, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098307/
https://www.ncbi.nlm.nih.gov/pubmed/37063895
http://dx.doi.org/10.3389/fimmu.2023.1121237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098307/
https://www.ncbi.nlm.nih.gov/pubmed/37063895
http://dx.doi.org/10.3389/fimmu.2023.1121237

Ejemplares similares